Buyers of healthcare companies are heavily scrutinizing potential healthcare and life science investments for compliance with increasingly onerous regulatory requirements, reimbursement risk and contractual risk. The Deal recently published our article on how private equity funds and healthcare business owners can prepare healthcare companies in advance for this scrutiny. Check out the article “Prepping Healthcare Portfolio Companies for Market“.
